PLEASE CONTACT THE STUDY COORDINATOR FOR THE TRIAL  OR THE ACADEMIC OFFICE OF CLINICAL TRIALS MAIN LINE AT 713.441.3250
FEATURED CLINICAL TRIALS
PARACHUTE IV implant study for heart failure

This study will evaluate the safety and effectiveness of the CKI Parachute implant in the treatment of patients with heart failure due to ischemic heart disease. The study is for patients with NYHA Class III or IV (Ambulatory) heart failure due to ischemic heart disease. Learn more >

TEAL study for HER2 positive breast cancer
Breast Cancer

This study will determine the Pathological Complete Response, which refers to complete disappearance of a tumor from the breast, when trastuzumab emtansine (TDM-1), lapatinib and Abraxane® are combined. This study is for patients with newly diagnosed HER2 positive breast cancer.  Learn more  >

Prevention of delayed graft function IN kidney transplantS

The purpose of this study is to test the safety of the drug Eculizumab and evaluate its use for the prevention of delayed graft function following kidney transplantation. Learn more > 

More to Explore